Skip to content
Search

Latest Stories

Sigma Pharmaceuticals wins national champion crown

INDIAN origin family-owned Sigma Pharmaceuticals won the ‘national champion’ crown at this year’s National Family Business Awards in the ‘health and care services’ category on Sunday (28).

The company said: “As we become a second-generation family business and continue to thrive and grow, this rewards the contribution of our extended family of over 500 valued colleagues, which is a fantastic achievement for us.”


Sigma Pharmaceuticals is owned and run by Indian origin family. It is located in Watford, Hertfordshire.

Employing over 350 staff, it is one of the largest independent short line pharmaceutical wholesalers in the UK. The company provides key services to the pharmaceutical industry, serving over 2,500 pharmacies, doctors, hospitals and care homes.

Sigma won the coveted award – given annually since 2008 to family-owned businesses in recognition of their extraordinary contribution to the British and Irish economies – just weeks after the company’s founder and CEO, Bharat Shah, was appointed CBE in the Queen’s Birthday Honours.

More For You

Warner Bros urges shareholders to reject Paramount's £80.75 billion bid, backs Netflix deal

Netflix wants Warner Bros' movie studio and HBO streaming service, gaining access to the company's extensive content library

Getty Images

Warner Bros urges shareholders to reject Paramount's £80.75 billion bid, backs Netflix deal

Highlights

  • Warner Bros board unanimously rejects Paramount Skydance's $108.4bn (£80.75bn) takeover bid.
  • Netflix's $72bn (£53.7bn) deal for film and streaming businesses deemed superior by board.
  • Paramount backed by billionaire Ellison family, while Netflix offer seen as better financed with clearer structure.

Warner Bros Discovery has told shareholders to reject Paramount Skydance's $108.4bn (£80.75bn) takeover bid, recommending instead a $72bn (£53.7bn) deal with Netflix for its film and streaming businesses.

The board "unanimously" agreed the Netflix deal was in the firm's best interests, despite Paramount claiming its offer was "superior" to the streaming giant's proposal.

Keep ReadingShow less